Bio-Techne Unveils Enhanced Leo System for Advanced High-Throughput Protein Analysis

Reuters
2025/12/09
Bio-Techne Unveils Enhanced Leo System for Advanced High-Throughput Protein Analysis

Bio-Techne Corporation has announced the expanded launch and first shipment of its next-generation Leo™ System, an advanced protein analysis platform powered by Simple Western™ Technology. The enhanced Leo System features dual-channel fluorescence and chemiluminescence detection, enabling researchers to analyze up to 24 protein targets per sample and process up to 100 capillaries within three hours. This investment in high-throughput, multiplexed protein analysis strengthens Bio-Techne's leadership in proteomic analytical instruments and supports compliance with 21 CFR Part 11. The new system is designed to accelerate research workflows and provide highly precise results, expanding Bio-Techne's capabilities in the life sciences sector.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG41626) on December 09, 2025, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10